To assess the tool's performance, researchers compared TrialGPT's results to those of three human clinicians who evaluated over 1,000 patient-criterion pairs. This comparison showed that TrialGPT could help clinicians connect their patients to clinical trial opportunities more efficiently, saving precious time that can be better spent on harder tasks that require human expertise.
Jeff Elton, CEO of ConcertAI, a vendor of data and AI SaaS platforms for clinical trial optimization, emphasized the importance of integrated digital trials. "With integrated digital trials, clinical studies are integral to the care process itself, versus being imposed on it," he said. "Trials don't need to place a higher burden on providers and patients than the standard of care."
Many health systems have also tested using analytical applications that can surface clinical trial opportunities for patients using their organizations' EHR data. In October, Microsoft announced new AI tools that will enable health systems to build their custom AI tools for various administrative needs, including clinical trial matching. However, bias in AI remains a concern for clinical outcomes. Yale School of Medicine researchers have highlighted how bias can surface in any algorithm development pipeline and worsen healthcare disparities.
Currently, around 20-25 patients rely on Crossing Healthcare's residential treatment services. The organization is dedicated to creating individualized discharge plans for each patient, enabling them to continue their treatment journey on an outpatient basis. This approach recognizes that every patient's recovery path is unique and aims to provide the most appropriate level of care.
Although the residential treatment service is closing, the outpatient services will remain unaffected. Patients will still have access to essential services such as medication management, behavioral health counseling, and group therapy. Additionally, the Transitions and apartment facilities for recovery housing will continue to operate, providing a stable environment for those in recovery.
Multiple staff members were informed on Monday that they would be laid off. Crossing Healthcare estimates that approximately 30 staff members are affected by this decision. However, the organization is hopeful that these affected staff will apply for the eight open positions available on campus. This provides an opportunity for them to continue their careers within the Crossing Healthcare family.
The COO's statement emphasized that the decision was based on a thorough analysis of financial and utilization data. The human resource department is working closely with the affected staff to offer support during this challenging time. Crossing Healthcare remains committed to its employees and is dedicated to helping them navigate this transition.
Crossing Healthcare began opening its healthcare buildings on the "Community Care Campus" in October 2019. This ambitious project was funded by a generous $60 million gift from the Howard G. Buffett Foundation. The Crossing Recovery Center, a medical detox and residential treatment facility, along with a transitional housing building with 60 beds, started operations in October 2019, admitting patients on October 15th.
Since its inception, Crossing Healthcare has been committed to providing comprehensive healthcare services. The closure of the residential treatment service is a part of their ongoing evolution and strategic planning to meet the changing needs of the community. WAND News is actively working to gather more information and will keep the public updated on any further developments.